IFNA1 and COVID-19: As opposed, impaired IFN-I/λ response following cell contact between SARS-CoV-2-infected cells and pDCs from severe COVID-19 patients, including those with anti-IFN-α antibodies, suggested a ‘silencing/unresponsive state’ of pDCs in this context.